510(k) · Cleared
ClearedNeurorecovery, Inc. (Nri) Comprehensive Intracranial Pressure Evaluation and Relief (Ciper) Kit
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Neurorecovery, Inc. · GWM Device, Monitoring, Intracranial Pressure
Cleared on Jul 19, 2005 as substantially equivalent to K822864 (Medex, Inc., 1982) and 1 other predicate after a 33-day review. Its family tree reaches back 1 generation to 1982.
- Decided
- Jul 19, 2005
- Review
- 33 days
- Class
- Class II
- Product code
- GWM
- Recalls
- None
- Predicates
- 2
Its longest line of descent runs back 1 generation to K822864 (1982). 2 ancestors in all. No later device cites it as a predicate yet.
- Root · 1 generation backK822864 Intracranial Pressure Monitoring DeviceMedex, Inc. · 1982 · Recalled
- This deviceK051599 Neurorecovery, Inc. (Nri) Comprehensive Intracranial Pressure…Neurorecovery, Inc. · 2005
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −1 | K822864 | Intracranial Pressure Monitoring Device | Medex, Inc. | 1982 | 1 |
| 0 (this device) | K051599 | Neurorecovery, Inc. (Nri) Comprehensive Intracranial Pressure Evaluation and… | Neurorecovery, Inc. | 2005 | — |
Other ancestors by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 2002 | 1 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in GWM? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
Top candidate predicates for a new GWM device
- #1 K252241 Pressio 3 Multi-parameter Neuromonitoring Systemscore 12.9 · 7 generations · no Class I recall
- #2 Held for the reportin the report
- #3 Held for the reportin the report
What was it cleared against? (2)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K822864 | Intracranial Pressure Monitoring DeviceSummary page 1…CFR 882.1620; ProCode: GWM) have been classified as Class II devices. 4. PREDICATE DEVICES * Medex, Inc. Intracranial Pressure Monitoring Device (K822864) * Medex, Inc. Transtar Intracranial Pressure Transducer (K020780) NeurorecoveryT M , Inc., July 11… | 1982 |
| * | K020780 | Transtar Intracranial Pressure Transducer, Model MX950ICPSummary page 1…s. 4. PREDICATE DEVICES * Medex, Inc. Intracranial Pressure Monitoring Device (K822864) * Medex, Inc. Transtar Intracranial Pressure Transducer (K020780) NeurorecoveryT M , Inc., July 11, 2005 Response to Request for Additional Information:… | 2002 |
What descends from it?
No later submission names this one as a predicate yet.
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
- 2 of the 2 ancestors have a recall of any class.
How does its category compare?
All GWM devicesGWM Device, Monitoring, Intracranial Pressure: FDA decisions, review times, recalls and adverse event reports over 20 years.
FDA decisions per year · GWM
1in 2025
2026 to Oct 25, outlined.
Median 510(k) review, days · GWM
30in 2020
Receipt to decision; years with fewer than 3 clearances left blank.
Recalls per year · GWM
3in 2025
Class I (3 since 2007) Class II/III not classified
Adverse event reports per year · GWM
441in 2025
MAUDE reports naming product code GWM, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 2 | — | 0 | 126 |
| 2008 | 2 | — | 1 | 105 |
| 2009 | 1 | — | 0 | 117 |
| 2010 | 2 | — | 9 | 104 |
| 2011 | 3 | 123 | 6 | 184 |
| 2012 | 4 | 100 | 1 | 151 |
| 2013 | 2 | — | 12 | 120 |
| 2014 | 2 | — | 2 | 360 |
| 2015 | 0 | — | 0 | 486 |
| 2016 | 3 | 192 | 0 | 419 |
| 2017 | 3 | 37 | 0 | 445 |
| 2018 | 1 | — | 0 | 302 |
| 2019 | 2 | — | 1 | 260 |
| 2020 | 3 | 30 | 0 | 268 |
| 2021 | 2 | — | 0 | 211 |
| 2022 | 0 | — | 0 | 424 |
| 2023 | 0 | — | 1 (1) | 744 |
| 2024 | 2 | — | 4 (2) | 641 |
| 2025 | 1 | — | 3 | 441 |
| 2026 | 1 | — | 0 | — |
What is it indicated for?
The Neurorecovery™, Inc., Neurorecovery Comprehensive Intracranial Pressure Evaluation and Relief Kit (NRI CIPER™ Kit) is intended for single patient use for the measurement of intracranial pressures (ICP) and drainage of Cerebral Spinal Fluid (CSF). It is intended for short term management of patients with increased intracranial pressure.
Indications for use as stated in the FDA summary.
https://510kreport.com/device/K051599 · printed Nov 6, 2026
Cite this page
510(k) Report. “K051599: Neurorecovery, Inc. (Nri) Comprehensive Intracranial Pressure Evaluation and Relief (Ciper) Kit.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K051599
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026